Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster
- 32 Downloads
Pancreatic cancer develops at approximately 25 weeks after 6 weeks of weekly subcutaneous administration of N-nitrosobis (2-oxypropyl)amine in the Syrian golden hamster. We studied the glucose tolerance and insulin secretion during the development of pancreatic cancer in this model. Every 6th week after start of treatment, glucose was infused intravenously for 30 min (10 mg/min). It was found that the glucose tolerance and glucose-stimulated insulin secretion were normal at 6, 12, and 18 weeks after start of treatment compared with agematched saline-injected controls. By contrast, after 24, 30, and 42 weeks an exaggerated plasma-glucose response and a concomitant impaired plasma-insulin response occurred during the glucose infusion (P<0.05). We therefore conclude that the development of pancreatic cancer in this model is accompanied by glucose intolerance and impaired insulin secretion, and that these effects occur concomitantly with the development of cancer.
Key wordsPancreatic cancer Nitrosamine Hamster Glucose tolerance Insulin secretion
Unable to display preview. Download preview PDF.
- 1.Ar'Rajab A, Ahreń B (1992) Long term diabetogenic effect of streptozotocin in rats. Pancreas (in press)Google Scholar
- 2.Berhowitz D, Greenberg L, Glassman S (1963) The intravenous tolbutamide test as a diagnostic aid in carcinoma of the pancreas. Am J Med Sci 243:150–154, 228–232Google Scholar
- 7.Dawishiba S, Pour PM, Stenram U, Sundler F, Andrèn-Sandberg Å (1992) Immunohistochemical characterization of endocrine cells in experimental exocrine pancreatic cancer in the Syrian golden hamster. Int J Pancreatol (in press)Google Scholar
- 12.Pour PM, Wilson RB (1990) Experimental tumors of the pancreas. In: Moosa AR (ed) Tumours of the pancreas. Williams & Wilkins, Baltimore London pp 37–158Google Scholar